A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (NCT03127631)

🧪 Interventions in This Study

• Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin) (DRUG)
• ACE inhibitor (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (61 Sites)

Showing the first 25 of 61 sites.

• Georgia Cancer Center at Augusta University — Augusta, Georgia
• University of Kansas Medical Center — Kansas City, Kansas
• University of Pennsylvania — Philadelphia, Pennsylvania
• UT Southwestern Medical Center — Dallas, Texas
• Westmead Hospital — Westmead, New South Wales
• Royal Adelaide Hospital — Adelaide, South Australia
• Flinders Medical Center — Adelaide, South Australia
• Centro de Pesquisa Clínica do Brasil — Brasília, Federal District
• Hospital Felício Rocho — Belo Horizonte, Minas Gerais
• Universidade Federal do Triângulo Mineiro — Uberaba, Minas Gerais
• Sociedade Hospitalar Angelina Caron — Campina Grande do Sul, Paraná
• Nucleo de Pesquisa Clinica Hospital do Rocio — Campo Largo, Paraná
• Centro Médico São Francisco — Curitiba, Paraná
• Instituto De Medicina Integral Prof. Fernando Figueira - IMIP — Recife, Pernambuco
• Instituto Nacional de Cardiologia — Rio de Janeiro, Rio de Janeiro
• Hospital de Caridade de Ijuí — Ijuí, Rio Grande do Sul
• Hospital de Clínicas de Porto Alegre — Porto Alegre, Rio Grande do Sul
• Irmandade Da Santa Casa De Misericórdia De Porto Alegre — Porto Alegre, Rio Grande do Sul
• Hospital Mae de Deus — Porto Alegre, Rio Grande do Sul
• Hospital Municipal de Barueri — Barueri, São Paulo
• Faculdade de Medicina da Universidade Estadual Paulista - Campus de Botucatu - UNESP — Botucatu, São Paulo
• Hospital Universitário São Francisco na Providência de Deus — Bragança Paulista, São Paulo
• Fundacao Doutor Amaral Carvalho — Jaú, São Paulo
• Fundação Faculdade Regional de Medicina de São José do Rio Preto — São José do Rio Preto, São Paulo
• Santa Casa de São Paulo (IPITEC) — São Paulo, São Paulo

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Prostate Cancer

• A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC — Homewood, Alabama
• A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described — Homewood, Alabama
• Stereotactic Ablative Radiation Therapy for Prostate Cancer — Charleston, South Carolina
• A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer — Basking Ridge, New Jersey
• A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer — Phoenix, Arizona
• Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer — Baltimore, Maryland

Explore by condition: All Prostate Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.